Baxion
Screening
Tags
Alerts
Theme
Inmed Pharmaceuticals Inc.
INM
·
NASDAQ
·
$1.72
Share Price as of 11/2
·
$3M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-K
FY 2026
09/09/26
10-Q
Q3 ended 03/31/26
05/06/26
10-Q
Q2 ended 12/31/25
02/11/26
10-Q
Q1 ended 09/30/25
11/06/25
10-K/A
FY 2025
10/24/25
Disclosures
Filter
8-K
Current report
09/18/26
8-K
Current report
07/22/26
8-K
Current report
07/10/26
8-K
Current report
06/10/26
8-K
Current report
05/19/26
Prospectuses and Registrations
Filter
424B3
Prospectus
10/28/26
424B3
Prospectus
10/01/26
S-4/A
Registration (business combination, amended)
09/29/26
S-4/A
Registration (business combination, amended)
09/09/26
S-4
Registration (business combination)
07/02/26
Proxies
Filter
DEF 14A
Definitive proxy
11/03/25
DEFA14A
Additional proxy materials
11/03/25
PRE 14A
Preliminary proxy
10/24/25
DEFA14A
Additional proxy materials
05/29/25
DEF 14A
Definitive proxy
05/16/25
Ownership
Filter
Form 4
Insider transaction
10/27/26
Form 4
Insider transaction
10/20/26
Form 4
Insider transaction
10/15/26
Form 4
Insider transaction
10/08/26
SC 13G/A
Beneficial ownership (amended)
10/07/26
Other
Filter
425
425
10/27/26
EFFECT
Request for effectiveness
10/01/26
425
425
09/09/26
425
425
07/22/26
425
425
07/22/26
Latest Filings
Filter
424B3
Prospectus
10/28/26
425
425
10/27/26
424B3
Prospectus
10/01/26
EFFECT
Request for effectiveness
10/01/26
S-4/A
Registration (business combination, amended)
09/29/26
Ownership
Filter
Form 4
Insider transaction
10/27/26
Form 4
Insider transaction
10/20/26
Form 4
Insider transaction
10/15/26
Form 4
Insider transaction
10/08/26
SC 13G/A
Beneficial ownership (amended)
10/07/26